DCM
NKTR icon

Dynamic Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Dynamic Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,047
Closed -$1.56M – 431
2016
Q3 		$1.56M Buy
+6,047
New +$1.56M 0.2% 161
2015
Q4 		– Sell
-5,914
Closed -$972K – 414
2015
Q3 		$972K Buy
+5,914
New +$1.05M 0.27% 150
2015
Q2 		– Sell
-7,307
Closed -$1.21M – 325
2015
Q1 		$1.21M Buy
7,307
+6,546
+860% +$1.35M 0.43% 50
2014
Q4 		$177K Buy
+761
New +$163K 0.09% 257
2014
Q3 		– Sell
-1,204
Closed -$232K – 407
2014
Q2 		$232K Buy
+1,204
New +$213K 0.07% 365
2014
Q1 		– Sell
-914
Closed -$156K – 478
2013
Q4 		$156K Sell
914
-4,486
-83% -$724K 0.03% 377
2013
Q3 		$846K Buy
+5,400
New +$998K 0.19% 191

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dynamic Capital Management's NKTR Position: Q4 2016 in Review

Dynamic Capital Management sold out of Nektar Therapeutics (NKTR) in Q4 2016, closing a stake of 6,047 shares — an estimated $1.56M sold.

Dynamic Capital Management first reported a position in NKTR in Q3 2013 and held it in 7 quarters. The position peaked at $1.56M in Q3 2016. 199 funds tracked by Wall St. Rank hold NKTR as of Q4 2016.

  • Dynamic Capital Management reported no remaining Nektar Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Dynamic Capital Management sold 6,047 Nektar Therapeutics shares in Q4 2016, an estimated $1.56M.
  • Dynamic Capital Management first reported a position in Nektar Therapeutics in Q3 2013 and held it in 7 quarters.
  • Dynamic Capital Management's Nektar Therapeutics position peaked at $1.56M in Q3 2016.
  • 199 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2016.

Based on Dynamic Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.